Skip to Content

TEVA 7543 (Duloxetine Hydrochloride Delayed-Release 30 mg)

Pill with imprint TEVA 7543 is Blue & White, Capsule-shape and has been identified as Duloxetine Hydrochloride Delayed-Release 30 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Duloxetine is used in the treatment of back pain; chronic pain; anxiety; depression; diabetic peripheral neuropathy and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Duloxetine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7543

Duloxetine hydrochloride delayed-release 30 mg TEVA 7543
Duloxetine hydrochloride delayed-release 30 mg TEVA 7543
Duloxetine hydrochloride delayed-release 30 mg TEVA 7543
Duloxetine hydrochloride delayed-release 30 mg TEVA 7543

Duloxetine Hydrochloride Delayed-Release

Imprint
TEVA 7543
Strength
30 mg
Color
Blue & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-7543

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.